Efficacy and Safety of Teriflunomide in Multiple Sclerosis across Age Groups: Analysis from Pooled Pivotal and Real-world Studies

BACKGROUND: Evidence suggests that efficacy and safety of disease-modifying treatments for multiple sclerosis may differ with age. We evaluate efficacy and safety of teriflunomide across age subgroups of patients from pooled clinical trials and real-world studies. METHODS: Post hoc analyses of patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Jiwon, Vukusic, Sandra, Tiel-Wilck, Klaus, Inshasi, Jihad Said, Rog, David, Baker, Darren P, Pyatkevich, Yelena, Poole, Elizabeth M, Vermersch, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330455/
https://www.ncbi.nlm.nih.gov/pubmed/34377047
http://dx.doi.org/10.1177/11795735211028781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330455/
https://www.ncbi.nlm.nih.gov/pubmed/34377047
http://dx.doi.org/10.1177/11795735211028781

Ejemplares similares